HEPTARES THERAPEUTICS

heptares-therapeutics-logo

Heptares Therapeutics is a drug discovery company focused on novel small-molecule drugs targeting G-protein-coupled receptors (GPCRs), the largest family of druggable targets. The Company has developed a unique, transformational and proprietary technology for making purified, stabilised and functional GPCRs (known as StaRs, Stabilised Receptors), overcoming a major limiting factor to the development of new drugs targeting this group.

#People #Financial #Website #More

HEPTARES THERAPEUTICS

Social Links:

Industry:
Biotechnology Pharmaceutical Therapeutics

Founded:
2007-01-01

Address:
Welwyn Garden City, Hertford, United Kingdom

Country:
United Kingdom

Website Url:
http://www.soseiheptares.com

Total Employee:
11+

Status:
Active

Contact:
+441707358628

Email Addresses:
[email protected]

Total Funding:
61.5 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Content Delivery Network Google Universal Analytics Font Awesome



Current Advisors List

fiona-marshall_image

Fiona Marshall Member of the Board of Directors @ Heptares Therapeutics
Board_member

anja-kรถnig_image

Anja Kรถnig Board Positions @ Heptares Therapeutics
Board_member

michael-steinmetz_image

Michael Steinmetz Board of Directors @ Heptares Therapeutics
Board_member

elliot-ehrich_image

Elliot Ehrich Scientific Advisory Boards @ Heptares Therapeutics
Advisor

malcolm-weir_image

Malcolm Weir Chairman of the Board of Directors @ Heptares Therapeutics
Board_member

Current Employees Featured

daniel-grau_image

Daniel Grau
Daniel Grau President @ Heptares Therapeutics
President

malcolm-weir_image

Malcolm Weir
Malcolm Weir Founder & CEO @ Heptares Therapeutics
Founder & CEO
2007-07-01

Founder


fiona-marshall_image

Fiona Marshall

malcolm-weir_image

Malcolm Weir

Acquisitions List

Date Company Article Price
2016-11-29 G7 Therapeutics G7 Therapeutics acquired by Heptares Therapeutics 12 M CHF
2014-12-26 JITSUBO JITSUBO acquired by Heptares Therapeutics N/A

Investors List

teva-pharmaceutical-industries_image

Teva Pharmaceutical Industries

Teva Pharmaceutical Industries investment in Venture Round - Heptares Therapeutics

takeda-ventures_image

Takeda Ventures

Takeda Ventures investment in Series B - Heptares Therapeutics

clarus-ventures_image

Clarus Ventures

Clarus Ventures investment in Series B - Heptares Therapeutics

stanley-family-foundation_image

Stanley Family Foundation

Stanley Family Foundation investment in Series B - Heptares Therapeutics

clarus-ventures_image

Clarus Ventures

Clarus Ventures investment in Series A - Heptares Therapeutics

mvm-life-science-partners_image

MVM Life Science Partners

MVM Life Science Partners investment in Series A - Heptares Therapeutics

novartis-venture-fund_image

Novartis Venture Fund

Novartis Venture Fund investment in Series A - Heptares Therapeutics

mvm-life-science-partners_image

MVM Life Science Partners

MVM Life Science Partners investment in Seed Round - Heptares Therapeutics

Official Site Inspections

http://www.soseiheptares.com Semrush global rank: 65.05 K Semrush visits lastest month: 1.75 M

  • Host name: 76.76.21.21
  • IP address: 76.76.21.21
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Heptares Therapeutics" on Search Engine